Extracellular Vesicles as Potential Biomarkers and Therapeutic Target in Gaucher Disease
Part of paid clinical trials in Minneapolis, Minnesota.
- Sponsor
- University of Minnesota
- Study ID
- NCT05843552
- Status
- Recruiting
Conditions
- Gaucher Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- no intervention — OTHERno intervention, this is an observational study
Study Details
This is an observational study intended to generate preliminary data to understand how lysosomal dysfunction can affect the biogenesis of extracellular vesicles, its content and function. The primary objective of the proposed project is to decipher how extracellular vesicle (EV) biogenesis and its role in intercellular communication can be impaired as a consequence of defects in lysosomal function. Collectively these defects in EV biogenesis and function can contribute to the neuroinflammation observed in lysosomal storage diseases. Since EVs can cross the blood-brain barrier, their characterization may be valuable in identifying novel biomarkers. In the presence of a GBA1 mutation, the decrease in GCase activity will lower overall lysosome function and increase the secretion of EVs. Further, there will be differences in EV size, its cargo including lipids, RNA and proteins and their aggregates. In comparison to healthy controls, EVs isolated from patients with Gaucher disease (GD) and GBA1 carriers is hypothesized to show significant differences in terms of its characteristics and content, which can contribute to our understanding of the link between lysosomes and neurological disease.
Key Dates
- Start date
- Aug 14, 2023
- Status verified
- Apr 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 30 participants (estimated)
Arms
- Arm: patients with GD
- Arm: obligate carriers
- Arm: healthy volunteers
Primary Outcome Measure
EVs quantity [ Time Frame: baseline ]
Central Contacts
- Reena Kartha, PhD, MS612-626-2436
- Marcia Terluk, PhD612-625-7972
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Minnesota | Minneapolis | Minnesota | 55414 |
Find similar trials in Minneapolis, MN
Related Studies
- International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registryRecruiting · Genzyme, a Sanofi Company · Phoenix, Arizona
- Genetic Studies of Lysosomal Storage DisordersEnrolling By Invitation · National Human Genome Research Institute (NHGRI) · Bethesda, Maryland
- A Long-term Follow-up Study of Gaucher DiseaseRecruiting · Duke University · Durham, North Carolina
- Gaucher Disease Outcome Survey (GOS)Recruiting · Shire · Lexington, Massachusetts